 There is currently no cure for ALS. Despite initial positive results in preclinical and early clinical studies, large-scale clinical trials with all agents except riluzole failed to demonstrate a clinically meaningful therapeutic effect in patients with ALS. Riluzole at the dose of 100 mgday showed a significant difference on survival 6.4; gain of 3 months and slowed deterioration in muscle strength. 